middle.news
Cyclopharm Hits Record $17.1 Million Revenue as US Technegas® Sites Reach 70
10:11am on Thursday 2nd of July, 2026 AEST
•
Healthcare
Read Story
Cyclopharm Hits Record $17.1 Million Revenue as US Technegas® Sites Reach 70
10:11am on Thursday 2nd of July, 2026 AEST
Key Points
1H FY26 revenue up 11% to $17.1 million
US Technegas® revenue surges 73% year-on-year
US installations reach 70 sites, pipeline exceeds 1,650 locations
International lung scintigraphy guidelines approved but publication delayed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cyclopharm (ASX:CYC)
OPEN ARTICLE